DSKX News Alert Ds Healthcare Group Inc (DSKX) 0.69 12/25/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ds Healthcare Group Inc (DSKX) 0.69 $DSKX

DS Healthcare Announces Its Long Awaited Marketing Initiative For Women
GlobeNewswire - Mon Dec 22, 1:50PM CST
DS Healthcare Group, Inc. (NASDAQ: DSKX), a leading developer of personal care products, launched a new marketing campaign to introduce its technology based products to a broader demographic. A striking model is shown in a laboratory environment to demonstrate the confluence of science and beauty.
DSKX: 0.69 (+0.01)

DS Healthcare wins regulatory approval to market its Spectral.LASH Eyelash extender in Brazil
M2 - Wed Nov 26, 4:06AM CST
Personal care products company DS Healthcare Group (NasdaqCM SKX) revealed on Tuesday the receipt of approval to market its Spectral.LASHeyelash extender product in Brazil.
DSKX: 0.69 (+0.01)

DS Healthcare Receives Regulatory Approval in Brazil to Market its Spectral.LASH Eyelash Extender
GlobeNewswire - Tue Nov 25, 8:45AM CST
DS Healthcare Group, Inc. (NASDAQ: DSKX), a leading developer of personal care products, today announced that the Brazilian Health Surveillance Agency, ANVISA, has approved the Company's Spectral.LASHeyelash extender product for marketing in Brazil.
DSKX: 0.69 (+0.01)

DS Healthcare Group CEO Daniel Khesin featured on The Gray Zone
PR Newswire - Mon Nov 17, 1:48PM CST
DS Healthcare Group CEO Daniel Khesin was featured on The Gray Zone on 880 The Biz on Nov. 14 to announce the launch of the DS Laboratories Hair Recovery Clinic (www.dshairclinic.com) in Coral Gables.
DSKX: 0.69 (+0.01)

DS Healthcare revenues up 2.4% in Q3
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 9:58AM CST

DSKX: 0.69 (+0.01)

DS Healthcare misses by $0.02, misses on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 7:51AM CST

DSKX: 0.69 (+0.01)

DS Healthcare Group Reports Third Quarter 2014 Financial Results As Company Reaches EBITDAS Profitability
GlobeNewswire - Mon Nov 17, 7:42AM CST
DS Healthcare Group, Inc. (NASDAQ: DSKX), a leading developer of personal care products, today announced financial results for the three and nine months ended September 30, 2014.
DSKX: 0.69 (+0.01)

DS Healthcare Group Issues Letter to Shareholders
GlobeNewswire - Fri Nov 14, 8:38AM CST
DS Healthcare Group, Inc. (NASDAQ SKX), a leading developer of personal care and specialty pharmaceutical products, today issued the following letter to shareholders:
DSKX: 0.69 (+0.01)

"New To The Street" Is Back on the Street
Marketwired - Thu Nov 13, 12:40PM CST
"New To The Street" was back on the street in NYC outside the See Thru Equity Conference, seethruequity.com, on 45th Street, interviewing several CEO's who were presenting at the micro-cap conference. We will be featuring these interviews on our website, NewToTheStreet.com on our segment called "On the Street Interviews."
DSKX: 0.69 (+0.01)

"New To The Street" to Broadcast Nationally
Marketwired - Tue Nov 11, 11:04AM CST
"New To The Street" will be airing nationally on the ION Network on December 4, 2014 at 9:30 am reaching 100M households.
DSKX: 0.69 (+0.01)

"New To The Street" Announces Upcoming Episodes, Clients, and Themes
Marketwired - Fri Nov 07, 2:30PM CST
"New To The Street" would like to introduce Hybrid Coating Technologies (OTCQB: HCTI) and its upcoming interview to be broadcast Monday, November 10th at 7:00 am on the ION Network WPXN, as well as our ongoing interviews with VizConnect (OTCQB: VIZC), HydroCarb Energy (OTCQB: HECC) and Larry Isen from the OTC Journal.
DSKX: 0.69 (+0.01)

"New To The Street" Television Show Completes an In-Depth Feature TV Interview With DS Healthcare Group (NASDAQ: DSKX)
Marketwired - Fri Oct 24, 1:48PM CDT
"New To The Street," a television show that profiles public companies across national TV networks and social media channels with in-depth anchor driven reporting, will be airing the first of a six-part series on Monday, October 27, 2014 at 7:00 am on ION's New York Flagship Station WPXN featuring DS Healthcare Group.
DSKX: 0.69 (+0.01)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Oct 24, 11:48AM CDT

SPRO: 1.72 (+0.08), SYNA: 69.57 (+0.11), ISR: 1.54 (+0.04), ADHD: 4.00 (+0.24), VTAE: 19.20 (+0.02), AEHR: 2.80 (+0.11), DSKX: 0.69 (+0.01), AMDA: 0.64 (-0.01), DRIV: 24.49 (+0.09), GIMO: 17.43 (+0.32), CBDE: 0.90 (+0.06), IVC: 16.80 (+0.20), P: 18.02 (-0.31), LAYN: 10.11 (+0.25), BJRI: 49.15 (+0.22), PGI: 10.55 (+0.01), HVB: 26.73 (-0.15), DRYS: 1.20 (-0.04), MMSI: 17.17 (+0.01)

UPDATE: "New to the Street" Locks in Mondays at 7:00am on ION's Flagstaff TV Station WPXN in New York Starting October 20th
Marketwire - Tue Sep 23, 11:56AM CDT
New to the Street will offer weekly access to our bio-type news series interviews with public and private company's CEO's every Monday at 7:00 am.
DSKX: 0.69 (+0.01)

DS Healthcare Group obtains regulatory sales approval in Middle East, reflecting 6% of the worldwide market
M2 - Fri Sep 05, 4:53AM CDT
Topical therapies company DS Healthcare Group reported on Thursday the receipt of regulatory approval for the sale of its products line in Middle East following its recent expansion into Brazil and China.
DSKX: 0.69 (+0.01)

DS Healthcare Group obtains regulatory approval in Middle East
GlobeNewswire - Thu Sep 04, 7:26AM CDT
This agreement comes on the heels of the Company's recent expansion into Brazil and China. International sales are a key driver of the Company's growth, as its breakthrough products are in high demand in Canada, Mexico, the UK, and Australia.
DSKX: 0.69 (+0.01)

DS Healthcare Group to Open its First DS Laboratories Hair Loss Clinic Offering Patients Unique Personalized Therapies for Hair Loss
GlobeNewswire - Tue Sep 02, 7:07AM CDT
DS Healthcare Group, Inc. (NASDAQ: DSKX), a leading developer of personal care products and specialty pharmaceuticals, today announced it will open its first DS Laboratories Hair Loss Clinic in Miami, Florida. Slated to open in the fourth quarter of 2014, the clinic will provide unique therapies and treatment options for patients who desire the most comprehensive approach to treating hair loss. A team of healthcare professionals led by a medical doctor will provide customized solutions with the most advanced proven technologies developed through DS Healthcare's clinical research to restore a full head of hair.
DSKX: 0.69 (+0.01)

DS Healthcare Group (DSKX) is Undervalued With Good Seasonality.
M2 - Fri Aug 22, 7:27AM CDT
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has updated its research report today on DS Healthcare Group (NASDAQ: DSKX). The report highlights the short term bullish seasonality that has emerged, the SqueezeTrigger Price of $2.51 and the projected fundamental valuation of $5.50 per share.
DSKX: 0.69 (+0.01)

BUYINS.NET Issues DS Healthcare Group (DSKX) SqueezeTrigger Report
M2 - Fri Aug 15, 7:20AM CDT
BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on DS Healthcare Group (NASDAQ: DSKX) after releasing the latest short sale data through August 13, 2014. The total aggregate number of shares shorted since May 2010 is approximately 2.08 million shares. Approximately 30% of daily trading volume is short selling. The SqueezeTrigger price for all DSKX shares shorted is $2.51. A short squeeze is expected to begin when shares of DSKX close above the $2.51 SqueezeTrigger price.
DSKX: 0.69 (+0.01)

DS Healthcare Group Reports Second Quarter 2014 Financial Results
GlobeNewswire - Fri Aug 15, 7:15AM CDT
DS Healthcare Group, Inc. (NASDAQ: DSKX), a leading developer of personal care products, today announced financial results for the three and six months ended June 30, 2014.
DSKX: 0.69 (+0.01)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 98

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Debevoise Builds Its PE M&A Bench With McBain Hire

Updated Category News Views 92

Law-firm hiring rarely makes a market blink, yet this one carries a decent whiff of where the deal work is gathering. Debevoise & Plimpton has brought Jenna McBain into its New York Mergers & Acquisitions Group as a partner, putting another experienced private-equity adviser on a platform the firm plainly intends to keep enlarging. McBain arrives from Weil, Gotshal &...

Continue Reading
Domino's Probe Puts Franchise Disclosure Under Lens

Updated Category News Views 110

A franchisee's shuttered stores can turn cheerful unit-growth talk into a nasty accounting of credibility, and that is the uncomfortable territory Domino's now occupies. Kahn Swick & Foti has opened an investigation into whether Domino's officers and directors breached fiduciary duties or violated state or federal law. That is not a finding of misconduct. It is a legal...

Continue Reading
CASEKOO's Montana Story Makes Brand Purpose Personal

Updated Category News Views 50

A blurry Montana kitchen, not a glossy product render, is doing the heavy lifting for CASEKOO this Thanksgiving. That is either a smart bit of brand discipline or a sentimental detour, depending on whether the company can make people feel something without losing sight of why they bought a phone case in the first place. Warmth Takes the Place of Hardware CASEKOO's new...

Continue Reading
Chord's $550 Million Exit Tightens Its Basin Focus

Updated Category News Views 69

One map pin just disappeared from Chord Energy’s corporate wall, and that matters more than the usual deal-closing confetti. Chord has completed the sale of its entire non-operated Marcellus position to POSCO International for $550 million in gross consideration. For shareholders in NASDAQ:CHRD, this is not a flashy new drilling story. It is a cleanup job, and sometimes...

Continue Reading
Tampa General's Food Bet Earns a 2026 Innovation Award

Updated Category News Views 78

Hospital meals have long been the punchline nobody bothered to fix, which is why Tampa General Hospital's latest recognition deserves a closer look. The not-for-profit academic health system was named the 2026 Inno Pick by the Tampa Bay Business Journal for its Food as Medicine initiative, its fifth straight year landing among the publication's Inno Award honorees. Awards...

Continue Reading
Alibaba Lawsuit Deadline Puts Disclosure Risk in Focus

Updated Category News Views 169

A calendar deadline is doing more work than any earnings headline for Alibaba shareholders this week. A securities class action notice says investors who bought or acquired Alibaba Group Holding Limited securities between May 23, 2024 and November 11, 2026 may seek appointment as lead plaintiff by January 19, 2027. That is a procedural milestone, not a verdict, and...

Continue Reading
Pinnacol’s Community Work Earns Denver Chamber Recognition

Updated Category News Views 67

A workers’ comp insurer usually becomes visible on somebody’s worst day; Pinnacol Assurance is being recognized for the work it keeps doing around those days. The Denver Metro Chamber of Commerce has given the Colorado-based, member-owned carrier its 2026 Business Impact Award for Corporate Social Responsibility. Awards can be cheap applause, frankly. This one...

Continue Reading
SEIA's Young Advisors Put Succession Plans to the Test

Updated Category News Views 67

A $166 million average book is not a cute training-program statistic. It says SEIA’s advisors aged 30 to 39 are already carrying serious client responsibility, and that matters because the registered investment advisory business is headed into a succession crunch nobody can solve with a glossy recruiting brochure. You Cannot Hand Off Trust Like a Spare Key Clients may...

Continue Reading
Webster First Takes Aim at the Youth Money Literacy Gap

Updated Category News Views 86

Money mistakes get expensive long before anyone calls them mistakes. That is the uncomfortable point beneath Webster First Federal Credit Union CEO John Thomasian's November 20, 2026 discussion of financial literacy: plenty of young adults are entering the real financial world with a card, a loan offer, and a phone full of banking apps, but no sturdy framework for using...

Continue Reading

Top 5 Most Recently Viewed Articles

Ross Gerber Expresses Optimism for Meta's Phone-Free Future

Updated Category News Views 242

Ross Gerber Praises Meta's Smart Glasses Technology Over the weekend, investor Ross Gerber expressed his admiration for Meta Platforms, Inc. (NASDAQ: META) smart glasses, affirming their potential to transform our relationship with technology. Gerber noted that this innovative eyewear gives him hope for a day when he might no longer rely on his smartphone. Smart Glasses:...

Continue Reading
Organ-on-a-Chip Market Insights and Future Projections

Updated Category News Views 118

Understanding the Organ-on-a-Chip Market Growth As technology evolves, the quest for more accurate and human-relevant drug testing models takes center stage. The Organ-on-a-Chip (OOC) market has emerged as a revolutionary force, previously valued at around USD 117.67 million, and now set to skyrocket to approximately USD 1.64 billion by 2032. This innovative approach is...

Continue Reading
Discovering Blue Light Cystoscopy Benefits in Bladder Cancer

Updated Category News Views 240

New Insights on Blue Light Cystoscopy and Bladder Cancer Photocure ASA, known as the Bladder Cancer Company, has made significant advancements in bladder cancer management with the recent study titled "Oncologic Outcomes of Blue Light Cystoscopy in an Equal Access Setting: Results of the BRAVO Study." This research published in JU Open Plus provides compelling evidence...

Continue Reading
BioCryst's Bold Move: Astria Therapeutics Acquisition Insights

Updated Category News Views 211

BioCryst Enhances HAE Portfolio with Astria Acquisition BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) has made a significant announcement regarding its acquisition of Astria Therapeutics, Inc. (NASDAQ: ATXS). This strategic move will strengthen BioCryst's position in the hereditary angioedema (HAE) market, as they plan to integrate Astria's promising therapies and...

Continue Reading
Milestone Scientific Reaches New Height with Strong Growth

Updated Category News Views 361

Milestone Scientific Achieves 52-Week High Milestone Scientific Inc. (NYSE: MLSS) has reached a significant milestone with its stock trading at $1.28, marking a 52-week high. This impressive achievement highlights the company's robust annual growth and increased investor confidence. As a result, the current market capitalization has reached approximately $97.37 million,...

Continue Reading